Actavis`s Generics Methylnaltrexone Br. Receives Approval in US
26 Aug 2024 //
FDA
Actavis Lab`s Generic Phentermine HCL;Topiramate Receives Approval in US
25 Jun 2024 //
FDA
Enforcement Report - Week of February 7, 2024
07 Feb 2024 //
FDA
Actavis` Generic Fidaxomicin Receives Approval in the U.S.
16 Jan 2024 //
FDA
Actavis`s Generic Treprostinil Approval in the U.S.
03 Apr 2023 //
FDA
Actavis` Generic Lacosamide Receives Approval in the U.S.
05 Jan 2023 //
FDA
Actavis Lab`s Generic Fesoterodine Fumarate Receives Approval in U.S.
04 Jan 2023 //
FDA
Actavis` Generic Posaconazole Receives Approval in the U.S.
30 Nov 2022 //
FDA
Actavis Inc Generic Acyclovir Receives Approval in US
01 Jul 2022 //
FDA
Actavis`s Generic Benzoyl Peroxide: Adapalene Receives Approval in US
22 Jun 2022 //
FDA
Enforcement Report - Week of February 9, 2022
09 Feb 2022 //
FDA
Actavis Lab`s Generic Fesoterodine Fumarate Receives Approval in the U.S.
11 Jan 2022 //
FDA
Actavis Lab`s Generic Scopolamine Receives Approval in the U.S.
10 Jan 2022 //
FDA
Actavis Laboratories FL, Inc. Receives FDA Warning (Close Out) Letter
07 Sep 2021 //
FDA
Actavis Marketed Testosterone Drug Off-Label, Ill. Jury Told
06 Aug 2021 //
LAW360
Actavis Settles Intuniv Generic-Delay Claims for $1.1 Million
25 May 2021 //
BLOOMBERGLAW
Actavis`s Generic Mesalamine Receives Approval in US
18 May 2021 //
FDA
How Pharma Cos. Can Evaluate Alliance Agreements` Validity
21 Sep 2020 //
LAW360
Former Actavis Head Of M&A Joins Psychedelics Company As CEO
30 Aug 2020 //
FORBES
Actavis`s Generic Mesalamine Receives Approval in US
22 Aug 2020 //
FDA
Actavis Elizabeth’s Generic Pregabalin Receives Approval In US
16 Jul 2020 //
FDA
States Sue Drug Companies, Executives Over Alleged Price Fixing
12 Jun 2020 //
REUTERS
Actavis ’s Generic Melphalan Hydrochloride Receives Approval In US
11 Mar 2020 //
FDA
Actavis Laboratories on Health Canada Inspection List
31 Dec 2019 //
HEALTH CANADA
Nalproprion Pharmaceuticals, Inc. v. Actavis Laboratories FL, Inc.
22 Aug 2019 //
PATENT DOCS
Sanofi patent case win holds off generic rivals for key cancer drug
16 Aug 2019 //
PMLIVE
Court upholds validity of patent protecting Relistor tablets
19 Jul 2019 //
THE PHARMALETTER
3 drugmakers dominated opioid supplies as 76B pills flooded the U.S.: report
18 Jul 2019 //
FIERCE PHARMA
Watson Lab`s Generic Penicillamine Receives Approval In US
24 Jun 2019 //
FDA
Actavis Generic Ranolazine Receives Approval in US
30 May 2019 //
FDA
Federal Circuit Affirms Validity of Endo Patent Morphinan Pain Relief Compounds
16 May 2019 //
IPWATCHDOG
Coripharma signs agreement with Teva to acquire Actavis’ R&D in Iceland
07 May 2019 //
PRESSS RELEASE
Watson Labs Generic Ambrisentan Receives Approval in US
30 Mar 2019 //
FDA
Long-standing issues result in warning letter for Teva
12 Mar 2019 //
IN-PHARMATECHNOLOGIST
Teva plant that makes schizophrenia drug tagged with warning
07 Mar 2019 //
FIERCE PHARMA
Actavis Laboratories FL, Inc Receives FDA Warning Letter
06 Mar 2019 //
FDA
Actavis Laboratories, FL. Inc on Health Canada Inspection List
06 Mar 2019 //
HEALTH CANADA
More Pain for Warner-Lambert and Their Pregabalin Patent
07 Feb 2019 //
PATENT DOCS
EU Regulatory Roundup: UK NHS Calls for Changes to Pricing Legislation
11 Jan 2019 //
RAPS
Irbesartan blood pressure and heart medication recalled from pharmacies by MHRA
03 Jan 2019 //
GOV UK
Class 2 Medicines Recall: Actavis recall of batches of Irbesartan / HCTZ Tablets
03 Jan 2019 //
GOV UK
Actavis Lab`s Generic Pimecrolimus Receives Approval in US
27 Dec 2018 //
FDA
FTC Approves Teva Petition to reopen Watson Pharms’ Acquisition of Actavis case
20 Dec 2018 //
FTC GOV
Actavis` Generic Methylphenidate Hydrochloride Receives Approval in US
15 Dec 2018 //
FDA
Valsartan products under recall - Updated November 27, 2018
28 Nov 2018 //
FDA
Aggrastat (tirofiban hydrochloride) : Medicure vs. Gland Pharma
24 Nov 2018 //
PATENT LITIGATION
Actavis Labs` Generic Azelaic Acid Receives Approval in US
21 Nov 2018 //
FDA
Actavis Labs` Generic Docosanol Receives Approval in US
21 Nov 2018 //
FDA
Pfizer loses drug patent fight in UK top court, may face claims
15 Nov 2018 //
REUTERS
Enforcement Report - Week of October 31, 2018
31 Oct 2018 //
FDA
Valsartan products under recall - Updated October 24, 2018
26 Oct 2018 //
FDA
Teva asks FTC to reopen Actavis and Watson merger decision
24 Oct 2018 //
FTC GOV
Actavis Labs `s Generic Pimecrolimus Receives Tentative Approval in US
19 Oct 2018 //
FDA
Allergan architect Bisaro exits board as revamp continues
30 Aug 2018 //
FIERCE PHARMA
Uceris (budesonide) : Valeant Pharmaceuticals et al v. Teva Pharmaceuticals et al
27 Aug 2018 //
PATENT LITIGATION